Navigation Links
VOICE study, a major HIV prevention trial for women, is launched in Zimbabwe
Date:9/16/2009

PITTSBURGH, SEPT. 16, 2009 Hopeful that some of the same antiretroviral (ARV) drugs used to treat HIV infection can also prevent it, researchers from the Microbicide Trials Network have enrolled the first participants into a new, large-scale clinical trial testing two approaches of the strategy in women.

The VOICE Study Vagina and Oral Interventions to Control the Epidemic will help determine whether applying a vaginal microbicide gel containing an ARV every day or taking an oral ARV tablet once a day can reduce a woman's risk of acquiring HIV.

While the study's primary aim is to evaluate the safety and effectiveness of the two regimens, an important question VOICE will also address is which of the two the tablet or the gel women will actually be more inclined to use. It is the first HIV prevention trial testing these two different approaches in the same study and the first effectiveness trial of a microbicide in which women use the gel every day instead of only at the time of sex.

Up to 5,000 women will be enrolled in VOICE at clinical trial sites in Uganda, South Africa, Zambia and Zimbabwe. Pending government approval, the study may also be conducted in Malawi. The Spilhaus Clinical Research Site at the University of Zimbabwe-University of California-San Francisco (UZ-UCSF) Clinical Trials Unit in Harare, began enrolling trial participants this week.

VOICE is being conducted under the leadership of the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), which is based at the University of Pittsburgh and Magee-Womens Research Institute.

"The HIV prevention field has not been without its share of disappointments. So, naturally we are excited that in VOICE we have not just one, but two promising approaches to evaluate. Hopefully, we'll find that ARVs, which helped turn the tide in the treatment of HIV, can be a prevention powerhouse, too," said Mike Chirenje, M.D., FRCOG, associate
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-916-3315
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Forterus Inc. Executives to Be Interviewed on VoiceAmerica
2. Audiopoint Adds Voice to Healthcare Reform Debate
3. AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE
4. Healthcare Providers Employ GHX OnDemand AP(SM) Solution to Automate and Streamline Invoice-to-Payment Process
5. Yorkshire and Humber NHS Procurement Hub Selects BigHand Voice Platform
6. Introducing Healthspottr: The New Voice of Healthcare Innovation
7. The Empire State Healthcare Coalition Voices Concern Over the Affordable Health Choices Act
8. The New York Times Website Patient Voices Series Features People Affected by Lupus
9. Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management
10. U-M study finds voice box can be preserved, even with the largest cancers
11. Skilled Nursing Care Coalition Voices Alarm About State Budget
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... CareSpan USA, Inc. announced today at the ... services agreement with Avera eCARE, a leading healthcare system ... Clinic in multiple states where Avera eCARE is licensed. ... joint services in remote and rural parts of North ... licensed. The two companies’ strategy is to focus on ...
(Date:9/21/2014)... Dallas, Texas (PRWEB) September 22, 2014 ... was originally launched in 1997, and is used ... children and adults. Its active ingredient, budesonide, is ... the corticosteroid receptor. AstraZeneca’s Pulmicort franchise includes the ... older than six years of age, Pulmicort Respules ...
(Date:9/21/2014)... an allergy to peanuts than raw peanuts, suggests an ... that specific chemical changes caused by the high temperatures ... body,s immune system, ,priming, the body to set off ... any peanuts. , The results might explain the difference ... the Western world compared to populations in East Asia, ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... enabled more generic drugs to inundate the market, thereby ... Pharmaceutical Manufacturing industry. According to data from Industry ... has cost the industry $1.8 and $2.5 billion in ... brand-name drugs losing patent exclusivity, which has hampered revenue ...
(Date:9/21/2014)... "I want to help people who ... haven’t the money for chiropractors," said an inventor from ... a product for myself." , The Stretch is a ... thigh muscles and align the spine properly. It improves ... of pinched nerves. Compact and easy to use, it's ...
Breaking Medicine News(10 mins):Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:Pulmicort Asthma Market (Epidemiology, Etiology, Symptoms, Diagnosis, Pathology) Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Pulmicort Asthma Market (Epidemiology, Etiology, Symptoms, Diagnosis, Pathology) Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Pulmicort Asthma Market (Epidemiology, Etiology, Symptoms, Diagnosis, Pathology) Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Dry roasting could help trigger peanut allergy 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3
... Oral Suspension Also Approved--, WILMINGTON, Del., Feb. 28 ... and Drug Administration (FDA) has,approved the use of NEXIUM(R) ... for the short-term treatment of gastroesophageal reflux,disease (GERD) for ... unmet,need for pediatric patients., NEXIUM received approval in ...
... Hospital has entered,into an agreement with VISICU, Inc., ... and remote monitoring tools, eICU,technology enables off-site critical ... around the clock. The voice, video and data,technology ... rates and shorten hospital length of stay., ...
... Education, Body Mass Index training events for, physicians and ... ... adults, INDIANAPOLIS, Feb. 28 With obesity at the forefront ... the Indiana Department of Health today announced that they will be,hosting ...
... (NEWARK, N.J., Feb. 28, 2008) New Jersey State ... Administration Research Education) Award for Excellence in Research to ... Flynn, assistant professor at the College of Nursing at ... honored with three other C.A.R.E. award recipients during the ...
... technologies and ... medical advancements, AUSTIN, Texas, Feb. ... officially opened the expansion of its,heart hospital today with the introduction ... as the number one overall,cardiac program in the State of Texas ...
... CHICAGO, Feb. 28 The Female Health Company,(Amex: ... John Snow, Inc., which,implements the USAID | DELIVER PROJECT, ... the United States Agency for International,Development (USAID) programs., ... international donors,of contraceptives and condoms. The Agency developed an ...
Cached Medicine News:Health News:FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old 2Health News:FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old 3Health News:FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old 4Health News:FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old 5Health News:The Christ Hospital and VISICU Sign Agreement to Implement eICU(R) Program 2Health News:Anthem Blue Cross and Blue Shield Teams with the State of Indiana to Combat Obesity 2Health News:Anthem Blue Cross and Blue Shield Teams with the State of Indiana to Combat Obesity 3Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 2Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 3Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 4Health News:The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units 2
(Date:9/19/2014)... Sept. 19, 2014 "Copay coupons," ... sales of brand drugs among patients with prescription drug ... to a new report  from the Department ... Inspector General (OIG). Federal anti-kickback laws prohibit suppliers ... are subsidized by the federal government. ...
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... to 2020″, provides key market data ... devices market. The report provides value, ... volume (in units) within market categories ... Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, ...
(Date:9/19/2014)... 2014 According to the ... Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications ... - Global Forecast to 2019" published by MarketsandMarkets, the ... $19,786.3 Million by 2019 from $14,240.0 Million in ... to 2019. Browse 74 market data ...
Breaking Medicine Technology:PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4
... SphygmoCor system plays key role in discovery, ... A,new study of more than 10,000 patients, conducted ... United Kingdom using AtCor Medical Holdings,Limited,s SphygmoCor(R) has ... as having "high normal" systolic blood pressure through,traditional ...
... 28 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ... oral and,poster presentations on its Cobalamin(TM) technology ... to Clinical Practice, taking,place from May 26-28 ... B12-Polymer Conjugates as Constructs for Targeted Tumor ...
Cached Medicine Technology:New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk 2New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk 3Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium 2Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: